A high value opportunity for vertical farming

A high value opportunity for vertical farming

As technologies emerge that enable a wide range of naturally occurring medicinal compounds to be reproduced by a host plant within a controlled environment, is it time to review the use of plants as biofactories? Innovation facilitators Agri-TechE are partnering with the life-sciences network OneNucleus to explore the market potential of using plant factories to mass produce rare drugs.

Contributing his expertise to the workshop is Malcolm Skingle, Director of Academic Liaison at GSK, who has seen the evolution of natural products over many years. GSK has dipped in and out of plant-derived pharmaceuticals and used alkaloids as starting points for novel chemistry programmes.

Continue reading.

Source:

Share



Hortibiz Newsradio
Tune in!

Hortibiz Newsradio

24/7 news and information

Stay up to date with Hortibiz Daily News.
Subscribe to Hortibiz Daily News!

Stay up to date with Hortibiz Daily News.

Horticultural news, market insights and technology

Career at Holland Hortimedia?
Apply!

Career at
Holland Hortimedia?

Content manager m/f – Sales manager m/f

Ads from tuinbouwmarktplaats.nl

Today on Hortibiz Newsradio, listen back to podcasts!